232 related articles for article (PubMed ID: 38541003)
1. Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies.
Agosti E; Zeppieri M; Antonietti S; Ius T; Fontanella MM; Panciani PP
J Pers Med; 2024 Feb; 14(3):. PubMed ID: 38541003
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Chordoma Genetic Aberrations and Targeted Therapies Panorama: A Systematic Literature Review.
Agosti E; Antonietti S; Zeppieri M; Ius T; Fiorindi A; Tel A; Robiony M; Panciani PP; Fontanella MM
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731241
[No Abstract] [Full Text] [Related]
4. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma.
Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163019
[TBL] [Abstract][Full Text] [Related]
7. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
9. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
10. Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets.
Nazeri E; Gouran Savadkoohi M; Majidzadeh-A K; Esmaeili R
Crit Rev Oncol Hematol; 2018 Nov; 131():102-109. PubMed ID: 30293700
[TBL] [Abstract][Full Text] [Related]
11. Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers.
Karim F; Amin A; Liu M; Vishnuvardhan N; Amin S; Shabbir R; Swed B; Khan U
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627127
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Pathways and Targets in Chondrosarcoma.
Micaily I; Roche M; Ibrahim MY; Martinez-Outschoorn U; Mallick AB
Front Oncol; 2021; 11():772263. PubMed ID: 34938658
[TBL] [Abstract][Full Text] [Related]
13. Role of glioma stem cells in promoting tumor chemo- and radioresistance: A systematic review of potential targeted treatments.
Agosti E; Zeppieri M; Ghidoni M; Ius T; Tel A; Fontanella MM; Panciani PP
World J Stem Cells; 2024 May; 16(5):604-614. PubMed ID: 38817336
[TBL] [Abstract][Full Text] [Related]
14. Advancing Craniopharyngioma Management: A Systematic Review of Current Targeted Therapies and Future Perspectives.
Agosti E; Zeppieri M; Antonietti S; Piazza A; Ius T; Fontanella MM; Fiorindi A; Panciani PP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255797
[TBL] [Abstract][Full Text] [Related]
15. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of the Metabolism of High-Grade Gliomas: Current Targeted Therapies and Future Perspectives.
De Maria L; Panciani PP; Zeppieri M; Ius T; Serioli S; Piazza A; Di Giovanni E; Fontanella MM; Agosti E
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255798
[TBL] [Abstract][Full Text] [Related]
17. IDH mutation status in a series of 88 head and neck chondrosarcomas: different profile between tumors of the skull base and tumors involving the facial skeleton and the laryngotracheal tract.
Tallegas M; Miquelestorena-Standley É; Labit-Bouvier C; Badoual C; Francois A; Gomez-Brouchet A; Aubert S; Collin C; Tallet A; de Pinieux G
Hum Pathol; 2019 Feb; 84():183-191. PubMed ID: 30296521
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic approaches in chondrosarcoma.
Polychronidou G; Karavasilis V; Pollack SM; Huang PH; Lee A; Jones RL
Future Oncol; 2017 Mar; 13(7):637-648. PubMed ID: 28133974
[TBL] [Abstract][Full Text] [Related]
19. Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype.
Kostine M; Cleven AH; de Miranda NF; Italiano A; Cleton-Jansen AM; Bovée JV
Mod Pathol; 2016 Sep; 29(9):1028-37. PubMed ID: 27312065
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]